CORVUS PHARMACEUTICALS
8.8000
07-十一月-24 15:59:59
15 分钟延时
股票
+0.0200
+0.23%
今日范围
8.4300 - 9.1000
ISIN
N/A
来源
NASDAQ
-
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
02 5月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
09 4月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
19 3月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
13 3月 2024 16:02:00 条件 Nasdaq GlobeNewswire
-
12 2月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
08 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
06 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
23 1月 2024 17:00:00 条件 Nasdaq GlobeNewswire
-
09 12月 2023 12:00:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
07 11月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
31 10月 2023 16:02:00 条件 Nasdaq GlobeNewswire
-
06 9月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
08 8月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
01 8月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
06 7月 2023 12:59:15 条件 Nasdaq GlobeNewswire
-
29 6月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
15 6月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Healthcare Conference
31 5月 2023 08:30:00 条件 Nasdaq GlobeNewswire